Related Experiment Video
Updated: Jun 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone
António Pedro Gonçalves1, Valdemar Máximo, Jorge Lima
1IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. apgoncalves@ibmc.up.pt
Abstract:
In order to investigate the cell death-inducing effects of rotenone, a plant extract commonly used as a mitochondrial complex I inhibitor, we studied cancer cell lines with different genetic backgrounds. Rotenone inhibits cell growth through the induction of cell death and cell cycle arrest, associated with the development of mitotic catastrophe. The cell death inducer staurosporine potentiates the inhibition of cell growth by rotenone in a dose-dependent synergistic manner. The tumor suppressor p53 is involved in rotenone-induced cell death, since the drug treatment results in increased expression, phosphorylation and nuclear localization of the protein. The evaluation of the effects of rotenone on a p53-deficient cell line revealed that although not required for the promotion of mitotic catastrophe, functional p53 appears to be essential for the extensive cell death that occurs afterwards. Our results suggest that mitotic slippage also occurs subsequently to the rotenone-induced mitotic arrest and cells treated with the drug for a longer period become senescent. Treatment of mtDNA-depleted cells with rotenone induces cell death and cell cycle arrest as in cells containing wild-type mtDNA, but not formation of reactive oxygen species. This suggests that the effects of rotenone are not dependent from the production of reactive oxygen species. This work highlights the multiple effects of rotenone in cancer cells related to its action as an anti-mitotic drug.
Insights
Rotenone, a mitochondrial inhibitor, induces cancer cell death and cell cycle arrest. While p53 is crucial for rotenone-induced cell death, its effects are independent of reactive oxygen species production.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Rotenone is a natural plant extract widely recognized as a mitochondrial complex I inhibitor.
- Its potential anti-cancer properties warrant investigation into its mechanisms of action in cancer cells.
Purpose of the Study:
- To investigate the cell death-inducing effects of rotenone in cancer cell lines.
- To elucidate the role of the tumor suppressor p53 in rotenone-induced cell death.
- To determine if rotenone's effects are dependent on reactive oxygen species production.
Main Methods:
- Treatment of various cancer cell lines with rotenone and staurosporine.
- Analysis of cell death, cell cycle arrest, mitotic catastrophe, and senescence.
- Assessment of p53 protein expression, phosphorylation, and nuclear localization.
- Evaluation of rotenone's effects on mitochondrial DNA-depleted cells.
Main Results:
- Rotenone inhibits cancer cell growth by inducing cell death, cell cycle arrest, and mitotic catastrophe.
- Staurosporine synergistically enhances rotenone's growth inhibitory effects.
- Functional p53 is essential for extensive cell death following rotenone-induced mitotic catastrophe.
- Rotenone induces cell death and cell cycle arrest in both mtDNA-depleted and wild-type cells, independent of reactive oxygen species generation.
Conclusions:
- Rotenone exhibits multiple anti-cancer effects, acting as an anti-mitotic drug.
- The tumor suppressor p53 plays a critical role in mediating rotenone-induced extensive cell death.
- Rotenone's cytotoxic effects on cancer cells are not dependent on reactive oxygen species production.
More Related Videos
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway

